Eric Schmidt, former CEO of Google and executive chairman of Alphabet, is currently using his capital to establishNon-profit organization focused on artificial intelligence and science, hoping to meet future scientific research needs through artificial intelligence technology.
The nonprofit organization will be led by Samuel Rodriques, founder of the Applied Biotechnology Laboratory at the Francis Crick Institute, a biomedical research center in London, and Andrew White, a professor at the University of Rochester in New York who uses artificial intelligence in chemistry research.
Eric Schmidt believes that artificial intelligence will completely change the way scientific research is done and will have a greater impact, so he believes that such technology must be mastered faster.
In addition to Eric Schmidt, many institutions are currently considering using artificial intelligence to study scientific methods. For example, Google has long used AlphaFold to analyze the structures of all proteins in the human body. The Taiwan Artificial Intelligence Laboratory, led by PTT founder Tu Yi-jin, has also analyzed more than 200 million genomic medicine documents through the genetic analysis platform TaiGenomics, jointly released with Microsoft. This platform allows artificial intelligence to establish genomic association networks and predictive models for genetic diseases, drug responses, and cancer.
As artificial intelligence accelerates the pace of various research, many market opinions believe that the pace of future research will no longer be limited to traditional steelmaking methods, but will be able to accelerate the production of research results at a faster pace. Especially after the emergence of automatically generated artificial intelligence computing methods in recent years, it will accelerate the development of more diverse artificial intelligence applications.
